The adjunctive use of glucagon-like peptide 1 receptor agonists (GLP-1 RA) as an addition to insulin is increasingly viewed as a method for addressing the rising prevalence of obesity in type 1 diabetes (T1D). Current GLP-1 RA drugs, such as semaglutide and the dual glucagon-insulinotropic peptide (GIP)/GLP-1 tirzepatide...
The Center For Mind & Esteem Development, Inc. A Course In Personal & Professional Development LoveNow360 For Self, Community & World Engagement & Empowerment Marvin Mack, Founder & Creative Director lovenow360.net
410-971-6235
personaldevelopment@me.com
Copyright © 2023 lovenow360 for Self, Community & World Engagement & Empowerment
The Center For Mind & Esteem Development, Inc.. All Rights Reserved
